| Viatris Pharma GmbH - Lenalidomid Viatris 5 mg, Hartkapseln | | 68557 | | 02 | | Lenalidomid Viatris 5 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 04.04.2022 | | |
| | Composition | | lenalidomidum 5.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Kapselhülle: titanii dioxidum, gelatina, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.807 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Active Agent | Dose |
|---|
| Lenalidomidum | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Lenalidomidum | 5 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | Amylum Pregelificatum | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Gelatina | | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Natrii Stearylis Fumaras | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Titanium Dioxide | | Kapselhülle |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 21 | 707.76 | 786.15 | A | SL | No |
|
|
